Bart Worp van der
1997 …2025

Research activity per year

Personal profile

Biography

Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He has been (co-)Chief Investigator of the randomised stroke trials HAMLET, PAIS, COOLIST, VAST, APACHE-AF, and MR ASAP and is Chief Investigator of PRECIOUS. He is a member of the Dutch CONTRAST consortium which aims to identify and test new treatments for patients with acute ischaemic stroke or intracerebral haemorrhage. He is former President of the European Stroke Organisation.

Side activities

2008 –          fellow of the European Stroke Organisation (ESO)

2011 – 2022 member of the Board of Directors of ESO

2011 – 2016 member of the Committee for Professional Interests (BBC) of the NVN

2013 – 2015 member of the Committee for Clinical trials of ESO

2013 – 2017 member of the Guideline Committee of ESO

2014 – 2016 vice-president ESO

2014 – 2021 member of the writing committee of the Dutch Stroke Guideline

2016 – 2018 president-elect ESO

2018 – 2020 president ESO

2019 – 2021 member of Committee on emergency prehospital care (45-minutennorm) of the Gezondheidsraad

2019 - 2020 consultant, Bayer

2020 – 2022 past president ESO

2020 – 2021 Chair module writing group ESO guideline on space-occupying oedema

2022 -          consultant, TargED

2022 -          national coordinator randomised trial, Bayer

 

Member of Data and Safety Monitoring Boards of randomised trials

2005 – 2007 Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis

2009 – 2011 Intrathecal methylprednisolone for intractable postherpetic neuralgia: STIP study. (Steroids for Intractable Postherpetic Neuralgia)

2009 – 2011 A randomised sequential trial of Lithium In amyotrophic lateral sclerosis

2015 – 2021 TELSTAR: Treatment of electroencephalographic status epilepticus after cardiopulmonary resuscitation - a randomized controlled trial (Chair)

2018 – 2019 PHALS: A placebo-controlled double blind randomized trial to investigate the efficacy and safety of the combination of Penicillin G / Hydrocortisone treatment in ALS patients (Chair)

2018 –          RESSTORE: Regenerative Stem Cell Therapy for Stroke in Europe

2019 –          GRECO: Ghrelin treatment of comatose patients after cardiac arrest: A phase 2 clinical trial to estimate safety and efficacy of ghrelin to promote cerebral (Chair)

External positions

national coordinator of an international trial - national coordination of this trial - Bayer

4 Mar 202431 Dec 3999

consultant - giving advice - TargED

1 Jan 202231 Dec 3999

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke: A Cluster Randomized Clinical Trial

    Hansen, D., Den Hartog, S. J., Van Leeuwen, N., Boiten, J., Dinkelaar, W., Van Doormaal, P. J., Eijkenaar, F., Emmer, B. J., Van Es, A. C. G. M., Flach, H. Z., Gons, R., Den Hertog, M. H., Imani, F., Janssen, P. M., Kortman, H., Kruyt, N. D., Kuhrij, L. S., Van Der Leij, C., Lo, T. H. R. & Van Der Lugt, A. & 19 others, Lycklama À Nijeholt, G., Martens, J. M. M., Nederkoorn, P. J., Piet, J., Remmers, M. J. M., Roos, Y. B. W. E. M., Silvis, S. M., Stolze, L. J., Stomp, W., Van Tuijl, J. H., Truijman, M. T. B., Vermeer, S. E., Van Walderveen, M. A. A., Van Den Wijngaard, I. R., Van Der Worp, H. B., Yo, L., Dippel, D. W. J., Lingsma, H. F. & Roozenbeek, B., 2025, In: JAMA Neurology. 82, 2, p. 160-167

    Research output: Contribution to journalArticleAcademicpeer-review

  • Endovascular treatment of patients with stroke caused by anterior cerebral artery occlusions

    Vos, E. M., Kappelhof, M., den Hartog, S. J., Coutinho, J. M., Emmer, B. J., Roozenbeek, B., van Zwam, W. H., van Oostenbrugge, R. J., van der Worp, H. B., Uyttenboogaart, M., van Es, A. C. G. M., Majoie, C. B. L. M., Dippel, D. W. J., Peeters-Scholte, C. M. P. C. D. & van den Wijngaard, I. R., Apr 2024, In: Acta Neurologica Belgica. 124, 2, p. 621-630 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

    Open Access
    File
    3 Downloads (Pure)
  • Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke

    Li, G., Lin, Y., Yang, J., Anderson, C. S., Chen, C., Liu, F., Billot, L., Li, Q., Chen, X., Liu, X., Ren, X., Zhang, C., Xu, P., Wu, L., Wang, F., Qiu, D., Jiang, M., Peng, Y., Li, C. & Huang, Y. & 31 others, Zhao, X., Liang, J., Wang, Y., Wu, X., Xu, X., Chen, G., Huang, D., Zhang, Y., Zuo, L., Ma, G., Yang, Y., Hao, J., Xu, X., Xiong, X., Tang, Y., Guo, Y., Yu, J., Li, S., He, S., Mao, F., Tan, Q., Tan, S., Yu, N., Xu, R., Sun, M., Li, B., Guo, J., Liu, L., Liu, H., Van Der Worp, H. B., 30 May 2024, In: New England Journal of Medicine. 390, 20, p. 1862-1872 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  • Metoclopramide to Prevent Pneumonia in Patients with Stroke and a Nasogastric Tube: Data from the PRECIOUS Trial

    Sluis, W. M., De Jonge, J. C., Reinink, H., Woodhouse, L. J., Westendorp, W. F., Bath, P. M., Van De Beek, D. & Van Der Worp, H. B., Oct 2024, In: Stroke. 55, 10, p. 2402-2408 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

    Open Access
    File
    2 Downloads (Pure)
  • Prevalence and 3-month follow-up of cerebrovascular MRI markers in hospitalized COVID-19 patients: the CORONIS study

    van Lith, T. J., Sluis, W. M., Wijers, N. T., Meijer, F. J. A., Ulzen, K. K. V., de Bresser, J., Dankbaar, J. W., de Mast, Q., Klok, F. A., Cannegieter, S. C., Wermer, M. J. H., Huisman, M. V., Tuladhar, A. M., van der Worp, H. B. & de Leeuw, F. E., Sept 2024, In: Neuroradiology. 66, 9, p. 1565-1575 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

    Open Access
    File
    1 Downloads (Pure)
Your message has successfully been sent.
Your message was not sent due to an error.